Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - ACCOUNTS PAYABLE
Accounts Payable NVAX - Novavax, Inc.
133 M
LAST VALUE
2.16%
2 YEAR CAGR
70.14%
5 YEAR CAGR
36.32%
10 YEAR CAGR